Complete coverage on


Latest Stories Andy Staples: Florida State's Fisher joins fight for cure of rare bone disorderupdated: Fri Aug 05 2011 16:29:00

TALLAHASSEE, Fla. -- During an interview in Florida State coach Jimbo Fisher's office on National Signing Day in February, Fisher's cell phone wouldn't stop ringing. On a day when the Seminoles landed one of the nation's top classes, the persistent caller wasn't a recruit. As the phone kept ringing, Fisher excused himself and answered.

Summer camp, sick kids, new world viewupdated: Mon May 02 2011 11:06:00

In 1996, when she was 4 years old, Catherine MacLean learned she had aplastic anemia. For seven years, she lived from hospital visit to hospital visit, one transfusion to the next. It wasn't until the summer of 2002 that her world suddenly included what was possible beyond the walls of her illness. She was 11.

Could I be getting too much iron?updated: Mon Dec 13 2010 08:57:00

I began taking an iron supplement because I thought I might have a case of running-induced anemia. It seemed to help, but now I wonder if I should continue taking the supplement or let it go. Am I getting too much iron?

Coroner: No indication mold killed Brittany Murphy or Simon Monjackupdated: Mon Jul 26 2010 14:33:00

A coroner's investigator dismissed online speculation that the pneumonia deaths of actress Brittany Murphy and her husband, Simon Monjack, may both have been related to viral mold inside their Los Angeles home.

Coroner finds Simon Monjack's death was similar to Brittany Murphy'supdated: Wed Jul 21 2010 20:54:00

Simon Monjack's death two months ago was caused by acute pneumonia and severe anemia, according to a Los Angeles County coroner spokesman.

CNNMoney: Amgen, J&J fall on anemia drug studyupdated: Wed Feb 27 2008 12:15:00

Shares of Amgen and Johnson & Johnson took a hit Wednesday after a study showed their anti-anemia drugs increase the risk of blood clots and death in cancer patients. But the companies say it's old news.

CNNMoney: Amgen earnings, sales beat forecastupdated: Thu Jan 24 2008 18:05:00

Biotech Amgen on Thursday reported an increase in earnings and a decrease in sales for the fourth quarter, beating Wall Street's forecast.

TV reporter battles cancerupdated: Thu Jan 03 2008 13:50:00

CNN's Alina Cho talks with WCVB reporter Kelley Tuthill, who is chronicling her battle with breast cancer.

Fortune: How Amgen lost its biotech lusterupdated: Fri Dec 14 2007 04:27:00

Amgen, the nation's second-largest biotech, was once considered immune from the chronic problems facing old-line drugmakers. But these days Amgen has all the major symptoms of "Big Pharma disease:" regulatory run-ins, price competition from generic drugs, and a virtually empty pipeline of future medicines.

CNNMoney: Amgen shares rise on profit gainsupdated: Thu Jul 26 2007 05:05:00

Amgen reported a significant boost to second-quarter earnings Thursday after taking a large acquisition-related charge last year.

CNNMoney: Troubled Amgen's pipeline dreamsupdated: Fri Jul 06 2007 03:21:00

Amgen, king of the biotechs, sits on a shaky throne.

CNNMoney: Senate panel sets generic biotech pathupdated: Wed Jun 27 2007 07:29:00

A Senate panel voted Wednesday to set a path for generic drugmakers to seek approval of cheaper, copycat versions of expensive biotechnology medicines.

Fortune: The Weird Al of Wall Streetupdated: Wed Jun 06 2007 14:33:00

In the late 1960s, Don McLean penned the nostalgic anthem "American Pie" in part to respond to what he saw as the beginning of a dark era for the U.S. Similarly, in May of this year, Lazard Capital...

CNNMoney: Stocks bounce backupdated: Fri May 11 2007 10:19:00

Stocks jumped Friday morning, recovering some of the previous session's losses thanks to reports showing moderate economic growth and mild inflationary pressures.

CNNMoney: The bill that could rock biotechupdated: Mon Apr 30 2007 05:54:00

Lawmakers are pushing forward with legislation that could help create generic competition for Big Biotech, drastically lowering the costs of expensive biotech drugs and changing the landscape in the pharmaceutical industry forever.

CNNMoney: Amgen earnings meet forecastsupdated: Mon Apr 23 2007 16:11:00

The biotech Amgen reported first-quarter earnings Monday that matched expectations, though its revenue fell just short of forecasts.

CNNMoney: Cashing in on 'orphans'updated: Tue Mar 13 2007 15:11:00

Some of the most successful blockbuster drugs in the world treat diseases that most people have never heard of.

FDA issues new warnings on widely used anemia drugs updated: Mon Mar 12 2007 14:06:00

Federal health officials have issued stern new warnings for doctors to more carefully prescribe widely used anemia drugs that can increase the risk of death and other serious problems in patients with cancer and kidney disease.

CNNMoney: Feds scrutinize Amgen; investors dump stockupdated: Thu Mar 01 2007 11:52:00

Amgen's stock price tumbled Thursday, as investors grew concerned over federal scrutiny and safety issues concerning the biotech's top-selling anemia drugs.

CNNMoney: Amgen reports surge in earnings, salesupdated: Thu Jan 25 2007 15:09:00

A surge in Amgen Inc's fourth-quarter earnings fell short of analyst projections, but the company's sales topped expectations.

CNNMoney: Big recovery seen for Big Biotech in 2007updated: Wed Jan 10 2007 09:15:00

Biotechs didn't do so well in 2006, but analysts are expecting a strong recovery for 2007, particularly for Big Biotech.

CNNMoney: Amgen earnings jump 22 percent; beat forecastupdated: Mon Oct 23 2006 15:28:00

Amgen Inc. reported a surge in third-quarter earnings, beating Wall Street's forecast.

CNNMoney: Missing the $20 billion biogeneric boomupdated: Mon Aug 14 2006 13:22:00

A huge new industry - biogenerics - is waiting to be born.

CNNMoney: 2 Big biotechs ready for an upswingupdated: Wed May 10 2006 09:28:00

Amgen and Genentech stock prices soared in 2005, but they lost their hot stock status in '06 as prices plunged. Is Big Biotech ready for an upswing, or is it all downhill from here?

CNNMoney: Amgen results don't cheer analystsupdated: Tue Apr 18 2006 17:40:00

Amgen Inc., the world's biggest biotech developer, beat earnings expectations for the first quarter Tuesday, but analysts were still skeptical about the company's performance.

CNNMoney: Good times ahead for biotechsupdated: Wed Feb 22 2006 14:55:00

Drug sales, bolstered by Medicare coverage, are projected to keep rising for the next 10 years, and biotechs are expected to get the lion's share of that increase, while the more traditional Big Pharma companies get squeezed by generic drug makers.

CNNMoney: Amgen stock rises on cancer drug newsupdated: Fri Nov 04 2005 15:40:00

Amgen's stock price climbed for a second consecutive day after the biotech and its partner Abgenix unveiled new data for an anti-cancer antibody.

CNNMoney: Bitter pill? J&J sues Amgen: Reportupdated: Thu Oct 13 2005 06:10:00

Johnson & Johnson has reportedly filed an antitrust suit charging that biotech company Amgen illegally drove J&J's drug Procrit out of the market using illegal market leverage.

Fortune: Growing Against The Grain Amgen CEO Kevin Sharer stands accused of remaking the world's biggest biotech company in the image of updated: Mon May 03 2004 00:01:00

The Empire State ballroom at the Grand Hyatt Hotel in midtown Manhattan typically serves as the setting for the kind of stuffy, state-of-a-business luncheons that are more snooze inducing than buzz...

CNNMoney: Biotech's 800-pound gorillaupdated: Tue Apr 06 2004 17:43:00

Nokia's disappointing sales announcement and the resulting fallout in the tech sector makes a lot of nervous investors even jumpier. In particular, they fear that any earnings disappointments during the next few weeks may lead to sudden selloffs.

Fortune: Heroes of Manufacturing These innovators sail against the prevailing winds, discovering whole new worlds in updated: Mon Mar 17 2003 00:01:00

Lee Hood: the man who automated biology

Fortune: The Next Biohazardupdated: Mon Sep 02 2002 00:01:00

Johnson & Johnson stock got hammered in mid-July when the government launched an investigation into its plant in Puerto Rico that makes Eprex, a bioengineered medicine sold outside the U.S. to trea...

Money Magazine: Biotech Booms And Busts We picked five biotech stocks last year. One tripled. One cratered.updated: Sun Apr 01 2001 00:01:00

When we last wrote about biotech stocks back in May 2000, we warned that they have a gut-wrenching "tendency to boom, then bust." Sure enough, the sector has since plunged, soared, then plunged aga...

Money Magazine: As The Techs Slide, Amgen Climbsupdated: Sun Apr 01 2001 00:01:00

Once again, the tech stocks in the MONEY 30 were seriously slammed by Wall Street. Indeed, three companies--Cisco, Oracle and Sun Microsystems--each lost more than 25% of their value in the month e...

Money Magazine: Amgen climbs, Nike stumblesupdated: Sun Oct 15 2000 00:01:00

The MONEY 30, an index of blue-chip growth stocks at the forefront of today's economy, rose just 0.3%--to 4293--from Aug. 15 to Sept. 8 (January 1996 = 1000). Biotech giant Amgen was the best perfo...

Fortune: Patent Fight Sparks Biological Warfare in the Drug Industryupdated: Mon Jul 24 2000 00:01:00

As soon as the next few weeks, Judge William Young could issue a ruling from his crowded Boston courtroom in what is probably the most closely watched biotech battle ever. The issues the trial rais...

Fortune: AMGEN HOW TO KEEP THAT FAMILY FEELINGupdated: Mon Apr 06 1992 00:01:00

SIGNS OF HYPERGROWTH are everywhere at Amgen, the Thousand Oaks, California, biotechnology firm. Like an amoeba, the company, which already sprawls over 17 low-slung buildings, is fast engulfing it...

We recommend